Companies: 10,795·Total market cap: $144.5T
Cencora, Inc.

Cencora, Inc.

CORNYSEHealthcare● Active
$274.08
$-0.96(-0.35%)
Market Cap$53.3B
P/E Ratio
52W High$377.54
52W Low$244.82

Cencora, Inc. (COR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

COR · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $3.21B for FY2025 (fiscal year ending 2025-09-30), up 7.0% year-over-year The FCF margin was 1.0%. Five-year CAGR stands at +11.8%.

FY2025 Free Cash Flow$3.21B▲ +7.0% YoY
Trailing 12M (TTM)$1.56Btrailing 4 quarters sum
FCF Margin1.0%$3.21B ÷ revenue
3-Year CAGR+13.3%FY2022 → FY2025
5-Year CAGR+11.8%FY2020 → FY2025
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
cor free cash flow history · cor free cash flow chart · cor free cash flow growth rate · cor free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$3.21B▲ +7.0%1.0%
FY2024$3.00B▼ 13.2%1.0%
FY2023$3.45B▲ +56.5%1.3%
FY2022$2.21B▼ 1.0%0.9%
FY2021$2.23B▲ +21.3%1.0%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
cor free cash flow 2025 · cor free cash flow 2024 · cor free cash flow 2023 · cor operating cash flow

FCF valuation metrics

Cencora, Inc. (COR) trades at a FCF yield of 2.92% and a price-to-free-cash-flow ratio of 34.1x. FCF per share stands at $8.04, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
2.92%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$8.04
TTM FCF ÷ Shares Outstanding
Price / FCF
x34.1
Share Price ÷ FCF per Share
EV / FCF (TTM)
x40.7
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-09-30
cor price to free cash flow · cor free cash flow yield · cor free cash flow per share · cor price to cash flow ratio

Cash flow statement summary

For FY2025, Cencora, Inc. generated $3.88B in operating cash flow and spent 668M in capital expenditures, yielding $3.21B in free cash flow.

Operating Activities
+$3.88B
Cash from core business operations
2025-09-30
Investing Activities
−$4.98B
CapEx, acquisitions & investments
2025-09-30
Financing Activities
+$2.25B
Buybacks, dividends & debt
2025-09-30
FCF FormulaOperating CF ($3.88B) − |CapEx| (668M) = FCF ($3.21B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
cor cash flow statement · cor cash flow statement 2025 · cor operating cash flow · cor cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Cencora, Inc.
Cencora, Inc.YOU
COR
$3.21B+7.0%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Cencora, Inc. (COR) reported free cash flow of $3.21B for FY2025 (fiscal year ending 2025-09-30), up 7.0% year-over-year. The FCF margin was 1.0%.

Based on available data, Cencora, Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $3.69B in FY2015. The 5-year CAGR stands at +11.8%.

Cencora, Inc.'s FCF yield is 2.92% and price-to-FCF ratio is 34.1x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

COR free cash flow · 8 questions

Cencora, Inc. free cash flow was $3.21B for FY2025, up 7.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.56B.

COR free cash flowCOR FCFCOR FCF 2025COR free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Cencora, Inc. · Cencora, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026